Business & Industry
Jazz AbCellera Alliance Targets Next-Generation Cancer Drugs
Jazz Pharma has entered into a major collaboration with AbCellera focused on advancing cancer immunotherapy programmes, signing an agreement that could ultimately exceed $4 billion in value. Under the arrangement, the companies will work on up to five multispecific...
Business & Industry
Alzheimer’s Drug Packaging Expansion Receives UK Funding
Eisai is moving ahead with a major upgrade of its manufacturing facility in Hatfield, Hertfordshire, backed by support from the United Kingdom’s Life Sciences Innovative Manufacturing Fund (LSIMF). The Japanese drugmaker is investing approximately 48 million pounds sterling ($64.5...
Business & Industry
Recipharm Investment Expands US Sterile Manufacturing
Recipharm has unveiled a multi-million-dollar investment in its US operations aimed at increasing sterile fill and finish manufacturing capacity for biologics and advanced therapies. The expansion comes after the company secured a clinical biologics fill and finish agreement with...
Business & Industry
IQVIA AI Expands Pharma Reach to NP and PA Prescribers
IQVIA Digital has introduced new technology designed to help pharmaceutical marketers better identify nurse practitioners (NPs) and physician associates (PAs) who prescribe medicines, using insights obtained from POCN Group, the social and professional community for NPs and PAs that...
Business & Industry
FDA and MHRA Launch New Liaison Programme to Strengthen Regulatory Collaboration
The US Food and Drug Administration (FDA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) have announced a significant new liaison programme designed to deepen regulatory collaboration between the two agencies. The initiative, unveiled during the DIA...
Business & Industry
Sanofi Advances T1D Treatment with Tzield FDA Approval in US
The US Food and Drug Administration (FDA) has granted accelerated approval to Sanofi’s Tzield (teplizumab-mzwv) for children aged eight to 17 years who have recently been diagnosed with stage 3 type 1 diabetes (T1D). The decision allows the therapy...
Business & Industry
Celltrion Expands Oncology Biosimilars Portfolio in Vietnam
Celltrion has strengthened its footprint in Vietnam by introducing two oncology biosimilars, further expanding its portfolio in one of Southeast Asia’s rapidly growing pharmaceutical markets. The company announced that commercial sales of Truxima (rituximab), used in the treatment of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read